Mediators of Inflammation / 2013 / Article / Fig 15

Research Article

Dose-Dependent Anti-Inflammatory and Neuroprotective Effects of an ανβ3 Integrin-Binding Peptide

Figure 15

(a) The IFN-γ levels in plasma samples measured by ELISA in different dose C16 treated groups. versus normal rats, versus vehicle control rats, and versus 0.5 mg/per day C16 treated EAE rats at 2 weeks after immunization. versus vehicle control rats; versus 0.5 mg/per day C16 treated EAE rats at 8 weeks after immunization. (a) The IFN-γ levels in plasma samples measured by ELISA in C16 late treated group. versus normal rats; versus vehicle control rats; versus 0.5 mg/per day C16 treated EAE rats; versus 1 mg/per day C16 treated EAE rats at 8 weeks after immunization. (c) The TGF-β levels in plasma samples measured by ELISA in different dose C16 treated group. versus normal rats. (d) The TGF-β levels in plasma samples measured by ELISA in C16 late treated group.
268486.fig.0015a
(a)
268486.fig.0015b
(b)
268486.fig.0015c
(c)
268486.fig.0015d
(d)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.